{"public_id":"cl_3d837288c85d680a312170f8629747c9","status":"active","superseded_by_public_id":null,"corpus_id":205099724,"text":"At a median follow-up of approximately 23 months, median overall survival had not been reached in either study group, with follow-up ongoing.","confidence":0.6,"paper":{"corpus_id":205099724,"title":"Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.","url":"https://sah.borca.ai/papers/205099724"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["review"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.6,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":3},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_22b8d08f3d0370e7c8de9f911eb1f106","name":"overall survival","description":"A secondary trial endpoint measuring time from randomization to death from any cause.","types":["outcome measure"],"url":"https://sah.borca.ai/concepts/co_22b8d08f3d0370e7c8de9f911eb1f106"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_3d837288c85d680a312170f8629747c9"}